Commitment to Excellence
Statistical Overview
Clinical Research
A Patient's Perspective
Guide to Caring
2003 Oncology Peer Review Committee
Hematology/Oncology
Ex-Officio
Department Representation
Back to Main Site
|
 |
 |
 |
|
St. Luke's Hospital is committed to the ongoing research and development of new cancer therapies and treatments. Clinical research is an integral part of the comprehensive cancer services offered at St. Luke's. Physicians are able to offer a variety of treatment and prevention options to their patients through well-respected local and national clinical trial groups.
St. Luke's Hospital is participating in a new study that looks at the relationship between sisters and breast cancer. The Sister Study is the only long-term study in the United States of women aged 35 to 74 who have sisters with breast cancer. The ultimate goal is to have 50,000 women participate in the study nationwide, coming from varied ethnic, racial and socio-economic backgrounds.
While the study is still in its early stages, only four U.S. cities have been invited to participate: St. Louis, Missouri; Phoenix, Arizona; Providence, Rhode Island; and Tampa, Florida.
St. Luke's Hospital was the first hospital in St. Louis to be a site for this study. In addition to the Sister Study, St. Luke's Hospital continues to be a part of the STAR Study. The STAR Study, the largest breast cancer prevention study conducted to date, will have 19,000 women enrolled by July 2004. St. Luke's has enrolled 47 women in the study. With the successful completion of the STAR Trial, St. Luke's Hospital plans to participate in the National Surgical Adjuvant Breast and Bowel Project's, new study (yet to be named) to promote continued options for women in their quest for breast cancer prevention strategies.
Comparison Data
Type
Prostate
Breast
Lung
Colon/rectum
|
 |
St. Luke's Hospital
19.7%
18.5%
11.4%
9.6%
|
 |
Missouri
11.8%
16.9%
15.5%
13%
|
 |
United States
16.5%
15.9%
13.9%
11%
|
|
|
 |
 |
|